ASP210: a Potent Oligonucleotide-Based Inhibitor Effective Against TKI-resistant CML Cells.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY（2024）
关键词
BCR-ABL1,chronic myelogenous leukemia,oligonucleotide therapeutics,resistance to therapy,tyrosine kinase inhibitors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要